10 Results for "

NCoA1

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "NCoA1" in MCE Product Catalog:

Cat. No.: HY-RS09089
Research Areas:  

Others

NCOA1 Human Pre-designed siRNA Set A contains three designed siRNAs for NCOA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS22672
Research Areas:  

Others

Ncoa1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ncoa1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS29186
Research Areas:  

Others

Ncoa1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ncoa1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
loading...
    loading...
Cat. No.: HY-146288
CAS No.: 2978788-07-5
Target:  

LXR

Research Areas:  

Metabolic Disease

LXR agonist 2 (compound 18rr) is a potent LXR (liver X receptor) agonist. LXR agonist 2 can stabilize NCOA1 (co-activator), leading to LXR agonism [1].
loading...
    loading...
Cat. No.: HY-173033
CAS No.: 2530027-71-3
MI-883 is orally active constitutive androstane receptor (CAR) (EC50 of 73 nM) agonist and pregnane X Receptor (PXR) (IC50 of 100 nM) antagonist. MI-883 binds to CAR and PXR ligand-binding domains, promotes CAR LBD assembly, activates CAR3 variant, stimulates CAR cytoplasmic-nuclear translocation, upregulates CAR target genes, recruits coactivators NCOA1, NCOA2, NCOA3, inhibits basal and agonist-induced PXR activation, downregulates PXR target genes, disrupts PXR-NCOR2 interaction, blocks agonist-mediated PXR-NCOA1 recruitment. MI-883 reduces plasma total cholesterol, LDL cholesterol, and hepatic free cholesterol levels, increases fecal bile acid excretion, regulates genes involved in xenobiotic metabolism, cholesterol homeostasis, and bile acid homeostasis. MI-883 exhibits metabolic stability, liver-predominant distribution, a safety profile with no observed toxicity, and does not stimulate human hepatocyte hypertrophy or hyperplasia. MI-883 can be used for the research of diet-induced hypercholesterolemia [1].
loading...
    loading...
Cat. No.: HY-P81990
Synonyms: bHLHe74; mNRC 1; NCoA 1; RIP160; SRC 1

Host:  

Rabbit

Application:  

WB, IHC-P, IP

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P81990A
Synonyms: bHLHe74; mNRC 1; NCoA 1; RIP160; SRC 1

Host:  

Rabbit

Application:  

WB, IHC-P, IP

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-189199
CAS No.: 3093981-26-8
SARS-CoV-2-IN-124 is an antiviral compound. SARS-CoV-2-IN-124 directly binds to NCOA1 and promotes its lysosome-dependent degradation. SARS-CoV-2-IN-124 downregulates the expression of lipogenic enzymes FASN and SCD1. SARS-CoV-2-IN-124 inhibits SARS-CoV-2 replication in multiple cell lines. SARS-CoV-2-IN-124 can be used for research related to SARS-CoV-2 infection [1].
loading...
    loading...
Cat. No.: HY-P80339
Synonyms: BHLHE74, SRC1, NCoA1, Nuclear receptor coactivator 1, NCoA-1, Class E basic helix-loop-helix protein 74, Protein Hin-2, RIP160, Renal carcinoma antigen NY-REN-52, Steroid receptor coactivator 1, bHLHe74, SRC-1

Host:  

Rabbit

Application:  

WB, IHC-P, IP

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-160126
CAS No.: 2154373-60-9
Target:  

LXR

Research Areas:  

Others

27-Norcholestenoic acid is an inverse agonist of LXRβ and LXRα that decreases basal luciferase activity and inhibits agonist-induced transactivation. 27-Norcholestenoic acid induces conformational changes in the AF-2 domain that favor corepressor over coactivator recruitment, thereby destabilizing the active receptor conformation. 27-Norcholestenoic acid downregulates FASN and SREBP-1a/c gene expression [1] .
loading...
    loading...